Maritza McIntyre, Ph.D., joined StrideBio as Chief Development Officer in April 2020. Dr. McIntyre is a virologist with over 20 years of experience in the development, evaluation and regulation of gene therapy, biological and small molecule products. Prior to joining StrideBio, Dr. McIntyre served as President of Advanced Therapy Partners, Executive Vice President of Regulatory Affairs and Product Development and Gene Therapy Clinical Project Lead at Bamboo Therapeutics (a Pfizer company), Vice President of Regulatory Affairs at REGENXBIO, and Chief of the Gene Therapy Branch at the U.S. Food and Drug Administration (FDA), among other notable industry leadership roles. Dr. McIntyre is a member of the Boards of the American Society of Gene and Cell Therapy (ASGCT) and GenSight Biologics. She holds a Ph.D. in Virology from the University of Chicago and B.S. in Biology from Wayne State University.
Maritza McIntyre, Ph.D.
CHIEF DEVELOPMENT OFFICER